Pharmacotherapy neuropathic low back pain

Current Pain and Headache Reports

Volumn 7, Issue 3, 2003, Pages 178-187

  Moskowitz, Michael H ^a  

^a Bay Area Pain Medical Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; AMFEBUTAMONE; ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIINFLAMMATORY AGENT; BACLOFEN; BENZODIAZEPINE; CALCIUM CHANNEL BLOCKING AGENT; CAPSAICIN; CITALOPRAM; ESCITALOPRAM; FENTANYL; GABAPENTIN; KETAMINE; LIDOCAINE; MIRTAZAPINE; MORPHINE; OMEGA CONOTOXIN MVIIA; OPIATE; OXYCODONE; SERTRALINE; TIAGABINE; TOPICAL AGENT; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VENLAFAXINE; ZOLPIDEM;

BODY WEIGHT DISORDER; CENTRAL NERVOUS SYSTEM; CHRONIC INFLAMMATION; CHRONIC PAIN; CLINICAL TRIAL; CLOSED ANGLE GLAUCOMA; CONFUSION; CONSTIPATION; DENTAL CARIES; DIZZINESS; DROWSINESS; DRUG DEPENDENCE; DRUG ERUPTION; DRUG MECHANISM; DRUG TOLERANCE; EDEMA; GASTROINTESTINAL HEMORRHAGE; HEART ARRHYTHMIA; HUMAN; HYPONATREMIA; HYPOTENSION; LIVER TOXICITY; LONG TERM CARE; LOW BACK PAIN; MECHANICAL STRESS; MEMORY DISORDER; MOLECULAR DYNAMICS; NAUSEA; NEUROANATOMY; NEUROPATHY; NEUROPHYSIOLOGY; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PERIPHERAL NERVOUS SYSTEM; RESTLESSNESS; REVIEW; SEXUAL DYSFUNCTION; SWEAT GLAND DISEASE; ULCER; URINE RETENTION; VOMITING; XEROSTOMIA; NEUROLOGIC DISEASE;

HUMANS; LOW BACK PAIN; NERVOUS SYSTEM DISEASES;

EID: 0037492262     PISSN: 15313433     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11916-003-0071-8     Document Type: Review

References (35)

1. Kawakami M: Anatomy, biochemistry, and physiology of low back pain. In Spine Care. Edited by White A, Schofferman J. St Louis: Mosby; 1995:84-103.
2. Selby D: The structural degenerative cascade: lumbar. In Spine Care. Edited by White A, Schofferman J. St. Louis: Mosby; 1995:8-15.
3. Bogduk N, Tynan W, Wilson AS: The nerve supply to the human vertebral disc. J Anat 1981, 132:39-56.
4. Crock HV: Internal disc disruption: a challenge to disc prolapse 50 years on. Spine 1986, 11:650-653.
5. Selby D: The structural degenerative cascade: lumbar. In Spine Care. Edited by White A, Schofferman J. St. Louis: Mosby; 1995:15.
6. Kawakami M, Kenici C, Weinstein J: Anatomy, biochemistry, and physiology of low back pain. In Spine Care. Edited by White A, Schofferman J. St. Louis: Mosby; 1995:92-94.
7. Bogduk NApril C, Derby R.: Discography. In Spine Care. Edited by White A, Schofferman J. St. Louis: Mosby; 1995:221-224.
8. Burton CV: Lumbosacral arachnoiditis. Spine 1978, 3:24-30.
9. Weinstein JN: Anatomy and neurophysiologic mechanism of spinal pain. In The Adult Spine: Principles and Practice. Edited by Frymayer, J, Ducker T, Hadler N, et al. New York: Raven Press; 1991:593.
10. Neuman S, Doubell TP, Woolf CJ: Inflammatory pain hypersensitivity mediated by phenotypic switch in myelinated primary sensory neurons. Nature 1996, 384:360-364.
11. Roberts WJ, A hypothesis on the physiological basis for causalgia. Pain 1986, 24:297-311.
12. Wasner G, Drummond P, Birklein F, Baron R: The role of the sympathetic nervous system in autonomic disturbances and "sympathetically maintained pain" in CRPS. In Complex Regional Pain Syndrome. Edited by Hardin RN, Baron R, Janig W. Seattle: IASP; 2001:107-109.
13. Black J, Dib-Hajj S, Cummins T, et al.: Sodium channels as therapeutic targets in neuropathic pain, In Neuropathic Pain: Pathophysiology and Treatment. Edited by Hansson P, Fields H, Hill R, et al. Seattle: IASP; 2001:22-29.
14. Fields HL, Hill RG: The near and far horizon. In Neuropathic Pain: Pathophysiology and Treatment. Edited by Hansson P, Fields H, Hill R, et al. Seattle: IASP; 2001:258-261.
15. Woolf CJ, Salter MW: Neuronal plasticity: increasing the gain in pain. Science 2000, 288:1765-1788.
16. Olney JW, Ishimaur MJ: Exitotoxic cell death, In Cell Death and Diseases of the Nervous System. Edited by Koliatsos V, Ratan R. New Jersey: Humana Press; 1999:199-202.
17. Coderre C: Excitatory amino acid antagonists: potential analgesics for persistent pain. In Novel Aspects of Pain Management. Edited by Sawynok J, Cowan A. New York: Wiley Liss; 1999:157-178.
18. Mao J, Price DD, Mayer DJ: Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions. Pain 1995a, 62:353-364.
19. Todd AJ, Maxwell DJ: GABA in the mammalian spinal cord. In GABA in the Nervous System. Edited by Martin D, Olsen R. Baltimore: Lippincott, Williams, & Wilkins; 2000:439-458.
20. Roberts E: Adventures with GABA. In GABA in the Nervous System. Edited by Martin D, Oslen R. Baltimore: Lippincott, Williams, & Wilkins: 2000:1-24.
21. Yaksh TL: Behavioral and anatomic correlates of the tactile-evoked allodynia produced by spinal glycine inhibition: effects of modulatory receptor systems and excitatory amino acid antagonists. Pain 1989, 37:111-123.
22. Blackburn-Munro G: Chronic pain, chronic stress, and depression: coincidence or consequence? J Neuroendocrinol 2001, 13:1009-1023.
23. Mathew SJ, Coplan JD, Smith ELP, et al.: Glutamate-hypothalamic-pituitary adrenal axis interactions: implications for mood and anxiety disorders. CNS Spectrums, 2001, 6:555-564.
24. Kramis RC, Gillette RG, Roberts WJ: Neurophysiology of chronic idiopathic back pain. In Spine Care. Edited by White A, Schofferman J. St. Louis: Mosby; 1995:11-113.
25. Janig W: CRPS1 and CRPS2 a strategic view. In Complex Regional Pain Syndrome. Edited by Hardin RN, Baron R, Janig W. Seattle: IASP Press; 2001:3-15.
26. Schofferman J: Long-term opioid analgesic therapy for severe intractable low back pain. Clin J Pain 1999, 15:136-140.
27. Schnitzer TJ, Gray WL, Paster RZ, Kamin M: Efficacy of tramadol in treatment of chronic low back pain. J Rheumatol 2000, 27:772-778.
28. Simpson RK, Edmondson EA, Constant CF, Collier C: Transdermal fentanyl as treatment for chronic low back pain. J Pain Symptom Manage 1997, 14:218-224.
29. Hunter JC: Voltage-gated ion channel modulators. In Novel Aspects of Pain Management: Opioids and Beyond. Edited by Sawynok J, Cowan A. New York: Wiley Liss; 1999:329-333.
30. Gaslinger G, Yaksh T: Spinal actions of cox inhibitors. In Proceedings of the 9th World Congress on Pain. Edited by Devor M, Rowbotham M, Wiessenfeld-Hallin Z, et al. Seattle: IASP; 2000:773.
31. Ossiprov M, Lai J, Malan P, et al.: Recent advances in the pharmacology of opioids. In Novel Aspects of Pain Management: Opioids and Beyond. Edited by Sawynok J, Cowens A. New York: Wiley Liss; 1999:55-60.
32. Dickenson A, Suzuki R: Function and dysfunction of opioid receptors in the spinal cord. In Opioid Sensitivity of Chronic Non-Cancer Pain. Edited by Kalso E, McQuay H, Wiesenfeld-Hallin Z. Seattle: IASP; 1999:17-44.
33. McQuay HJ, Tramer M, Nye BA, et al.: A systematic review of antidepressants in neuropathic pain. Pain 1996, 68:217-227.
34. Yaksh T: Alpha-2-agonists as analgesics. In Novel Aspects of Pain Management: Opioids and Beyond. Edited by Sawynok J, Cowens A. New York: Wiley Liss; 1999:179-202.
35. Bowery N, Marzia M: Gamma-aminobutyric acid and pain. In Novel Aspects of Pain Management: Opioids and Beyond. Edited by Sawynok J, Cowens A. New York: Wiley Liss; 1999:249-264.